Inhibition of neutral sphingomyelinase-2 perturbs brain sphingolipid balance and spatial memory in mice.
The sphingolipid ceramide is a bioactive signaling lipid that is thought to play important roles in modulating synaptic activity, in part by regulating the function of excitatory postsynaptic receptors. However, the molecular mechanisms by which ceramide exerts its effects on synaptic activity remain largely unknown. We recently demonstrated that a rapid generation of ceramide by neutral sphingomyelinase-2 (nSMase2; also known as "sphingomyelin phosphodiesterase-3") played a key role in modulating excitatory postsynaptic currents by controlling the insertion and clustering of NMDA receptors (Wheeler et al. [2009] J. Neurochem. 109:1237-1249). We now demonstrate that nSMase2 plays a role in memory. Inhibition of nSMase2 impaired spatial and episodic-like memory in mice. At the molecular level, inhibition of nSMase2 decreased ceramide, increased PSD-95, increased the number of AMPA receptors, and altered the subunit composition of NMDA receptors. Our study identifies nSMase2 as an important component for efficient memory formation and underscores the importance of ceramide in regulating synaptic events related to learning and memory.
Tabatadze
Nino
N
Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.
Savonenko
Alena
A
Song
Hongjun
H
Bandaru
Veera Venkata Ratnam
VV
Chu
Michael
M
Haughey
Norman J
NJ
D000704:Analysis of Variance; D000814:Aniline Compounds / Q000009:adverse effects; D000818:Animals; D001597:Benzylidene Compounds / Q000009:adverse effects; D001921:Brain / Q000378:metabolism*; D002518:Ceramides / Q000378:metabolism; D004195:Disease Models, Animal; D004791:Enzyme Inhibitors / Q000009:adverse effects; D013058:Mass Spectrometry / Q000379:methods; D018782:Maze Learning / Q000187:drug effects; D008569:Memory Disorders / Q000235:genetics* / Q000473:pathology*; D051379:Mice; D018345:Mice, Knockout; D013028:Space Perception / Q000187:drug effects / Q000502:physiology*; D013107:Sphingolipids / Q000378:metabolism*; D013108:Sphingomyelin Phosphodiesterase / Q000037:antagonists & inhibitors / Q000172:deficiency / Q000378:metabolism*
D000814:Aniline Compounds; D001597:Benzylidene Compounds; D002518:Ceramides; D004791:Enzyme Inhibitors; C468773:GW 4869; D013107:Sphingolipids; C491483:Smpd3 protein, mouse; D013108:Sphingomyelin Phosphodiesterase